[
  {
      "Company": "Aracari Biosciences",
      "Model": "Vascularized Micro-Organ (VMO)",
      "Organs/Tissues": "Generic human microvascular network + optional organ-specific cells",
      "Physiological/Pathological": "Primarily normal physiology (healthy microvasculature), can be used to study angiogenesis, vascular toxicity",
      "Cell Source": "Primary human endothelial cells (e.g. HUVEC) + pericytes/mesenchymal cells; can add parenchymal organ cells (optional)",
      "Multiple Cell Types": "Yes (endothelial + pericytes + optional organ cells)",
      "Stromal Cells": "Pericytes or mesenchymal stromal cells for vascular support; other organ stroma if added",
      "Tissue-resident Immune": "No (standard), can be added if needed",
      "Circulating Immune": "Possible to flow leukocytes in the vessel under perfusion",
      "Crosstalk (Multi-tissue)": "Not typically; single micro-organ unit unless customized",
      "Air-Liquid Interface": "No (fully fluid perfused)",
      "Extracellular Matrix": "3D collagen or fibrin gel supporting vessel network",
      "3D Scaffold": "Yes, a 3D gel where vessels self-assemble and organ cells can be embedded",
      "Notable Features": "Self-assembled human microvasculature under continuous flow, used for vascular biology or toxicity",
      "Plate/Format (Throughput)": "Custom microfluidic chips, low–medium throughput (~1–4 units/chip)",
      "Max Culture Duration": "Days to ~2 weeks for stable vascular networks",
      "Readouts - Live Imaging": "Yes, confocal imaging of 3D vessel formation in gel",
      "Readouts - Supernatant Sampling": "Yes, can collect outflow for secreted factors or small molecules",
      "Readouts - Cell Retrieval": "Possible at endpoint by digesting gel",
      "Readouts - Whole Tissue": "Yes, fix/stain in-chip or carefully extract gel for histology",
      "Readouts - TEER": "No (3D vasculature, barrier measured by tracer leakage)",
      "Readouts - MEA": "No",
      "Readouts - Integrated Biosensors": "No built-in; rely on imaging or external assays",
      "Dead Volume": "Low, small microchannels + gel region",
      "Perfused": "Yes, continuous flow through the microvessels",
      "Gas Mix Controlled": "Standard incubator (5% CO₂, 37°C); O₂ set by environment",
      "Real-time Microenvironment Control": "Flow/dosing controlled externally; can add stimuli or immune cells on demand",
      "model_availability": "Service-based (CRO) with in-house platform; not sold as standalone kit"
    },
    {
      "Company": "Aracari Biosciences",
      "Model": "Vascularized Micro-Tumor (VMT)",
      "Organs/Tissues": "3D human tumor co-cultured with microvascular network",
      "Physiological/Pathological": "Pathological (cancer): evaluate tumor growth, vascular interactions, immuno-oncology",
      "Cell Source": "Human endothelial cells + pericytes + tumor cells (cell lines or patient-derived)",
      "Multiple Cell Types": "Yes (tumor, endothelium, pericytes). Can add fibroblasts for TME",
      "Stromal Cells": "Yes, pericytes and possibly CAFs for tumor stroma",
      "Tissue-resident Immune": "Not standard; can incorporate if needed",
      "Circulating Immune": "Yes, can flow T-cells/CAR-T to model infiltration",
      "Crosstalk (Multi-tissue)": "Within the tumor microenvironment + vasculature; not multi-organ linking",
      "Air-Liquid Interface": "No",
      "Extracellular Matrix": "Collagen/fibrin 3D gel embedding tumor + vessels",
      "3D Scaffold": "Yes, tumor spheroid or cells in 3D + capillaries",
      "Notable Features": "Perfused tumor microenvironment, allows drug delivery via vessels, immune cell extravasation",
      "Plate/Format (Throughput)": "Custom microfluidic chips, low–medium throughput",
      "Max Culture Duration": "Days to ~2 weeks, capturing tumor–vessel interactions",
      "Readouts - Live Imaging": "Yes, confocal imaging of tumor, vessels, immune infiltration",
      "Readouts - Supernatant Sampling": "Yes, measure secreted factors or drug/metabolites in outflow",
      "Readouts - Cell Retrieval": "Yes, at endpoint by enzymatic gel digestion or partial dissection",
      "Readouts - Whole Tissue": "Yes, fix/stain entire vascularized tumor for morphological/IF analyses",
      "Readouts - TEER": "No, use permeability or leakage for barrier function",
      "Readouts - MEA": "No",
      "Readouts - Integrated Biosensors": "No built-in sensors; rely on imaging/assays",
      "Dead Volume": "Low microchannel system",
      "Perfused": "Yes, functional capillaries with flow mimicking blood supply",
      "Gas Mix Controlled": "Incubator environment",
      "Real-time Microenvironment Control": "User can vary flow, add drugs or immune cells, track real-time changes",
      "model_availability": "Service-based projects for oncology/immuno-oncology drug testing"
    },
    {
      "Company": "Aracari Biosciences",
      "Model": "Vascularized Micro-Brain (VMB)",
      "Organs/Tissues": "Human BBB model: brain microvascular endothelium + astrocytes + pericytes",
      "Physiological/Pathological": "Replicates healthy BBB with tight junctions, can test disruption or drug penetration",
      "Cell Source": "Primary human brain microvascular endothelial cells, astrocytes, pericytes",
      "Multiple Cell Types": "Yes (endothelium + astrocytes + pericytes). Immune not standard",
      "Stromal Cells": "Astrocytes/pericytes are essential glial/stromal for BBB",
      "Tissue-resident Immune": "Not by default (microglia can be added if needed)",
      "Circulating Immune": "Possible to flow immune cells in the vessel, but not typical",
      "Crosstalk (Multi-tissue)": "No (single BBB model, though could be part of broader system in R&D)",
      "Air-Liquid Interface": "No (fully fluid environment on both sides of the barrier)",
      "Extracellular Matrix": "Collagen/fibrin or matrix supporting 3D arrangement, enabling tight junctions",
      "3D Scaffold": "Yes, a 3D neurovascular unit with embedded endothelium & glia",
      "Notable Features": "Functional BBB traits (tight junction proteins, efflux transporters), perfused vasculature",
      "Plate/Format (Throughput)": "Custom microfluidic chips, low throughput",
      "Max Culture Duration": "Days to ~2 weeks, stable BBB phenotype",
      "Readouts - Live Imaging": "Yes, observe barrier integrity, fluorescent tracers crossing BBB, morphological changes",
      "Readouts - Supernatant Sampling": "Yes, measure drug crossing or secreted factors in outflow",
      "Readouts - Cell Retrieval": "Possible at endpoint, though more complex to dissect cell layers",
      "Readouts - Whole Tissue": "Yes, fix/stain for tight junction markers, astrocyte markers",
      "Readouts - TEER": "Not integrated; barrier function measured by tracer permeability",
      "Readouts - MEA": "No",
      "Readouts - Integrated Biosensors": "No built-in; rely on external permeability assays",
      "Dead Volume": "Low, microchannels",
      "Perfused": "Yes, flow simulating blood side, influences endothelium under shear",
      "Gas Mix Controlled": "Incubator environment",
      "Real-time Microenvironment Control": "Flow & drug dosing can be changed, can model inflammation or other disruptions",
      "model_availability": "Service-based for BBB penetration, neurotox assays"
    },
    {
      "Company": "Aracari Biosciences",
      "Model": "Vascularized Bone Marrow (in development)",
      "Organs/Tissues": "Human bone marrow niche (hematopoietic stem cells + stroma) + functional microvessels",
      "Physiological/Pathological": "Models normal hematopoiesis, drug-induced neutropenia, can be used for BM toxicity",
      "Cell Source": "Human CD34+ hematopoietic stem/progenitor cells, marrow stromal cells, endothelial cells",
      "Multiple Cell Types": "Yes (HSCs, stromal, endothelium). Immune lineages produced (e.g. neutrophils)",
      "Stromal Cells": "Marrow mesenchymal/stromal cells for niche support",
      "Tissue-resident Immune": "Bone marrow progenitors + developing neutrophils, etc.",
      "Circulating Immune": "Cells can exit marrow into vascular channel, simulating bloodstream release",
      "Crosstalk (Multi-tissue)": "No, single bone marrow environment with perfused vessel",
      "Air-Liquid Interface": "No",
      "Extracellular Matrix": "Collagen/fibrin gel for BM niche + endothelial support",
      "3D Scaffold": "Yes, a 3D hematopoietic microenvironment with vascular bed",
      "Notable Features": "Demonstrates neutrophil production & egress, can predict neutropenia from chemo drugs",
      "Plate/Format (Throughput)": "Custom microfluidic prototypes, low throughput",
      "Max Culture Duration": "Days to a few weeks for hematopoiesis; still in R&D",
      "Readouts - Live Imaging": "Yes, can visualize emerging neutrophils and vessel interactions",
      "Readouts - Supernatant Sampling": "Yes, measure cytokines or track cells in outflow",
      "Readouts - Cell Retrieval": "Yes, can isolate released cells or dissect the niche at endpoint",
      "Readouts - Whole Tissue": "Yes, can fix entire BM compartment for histology",
      "Readouts - TEER": "No",
      "Readouts - MEA": "No",
      "Readouts - Integrated Biosensors": "No built-in, rely on imaging / external assays",
      "Dead Volume": "Low, small channel design",
      "Perfused": "Yes, recapitulating marrow sinusoidal flow",
      "Gas Mix Controlled": "Incubator environment, possibly varying O₂ for BM physiology",
      "Real-time Microenvironment Control": "Flow/dosing can be changed, add G-CSF or chemo to observe blood cell output changes",
      "model_availability": "Emerging service, funded by NIH SBIR; not fully commercial yet"
  }
]
